Consultation on the Notice of Intent to Interested Parties: Tamper Resistance under the Controlled Drugs and Substances Act

Notice to the reader:

The online consultation is now closed. Comments and suggestions received during the public consultation period are being considered. Thank you for your input.

The abuse of prescription drugs is a serious public health and safety issue for many communities across Canada.

As part of the Government's comprehensive approach to addressing prescription drug abuse, Health Canada is consulting with Canadians on proposed regulations, under the Controlled Drugs and Substances Act that would require that drugs at high risk for abuse, like controlled-release oxycodone, have tamper-resistant properties before they can be sold in Canada.   The attached  Notice to Interested Parties provides background on the issue of prescription drug abuse as well as an outline of the proposed regulation.

How to Get Involved

The consultation is open for comment starting June 28, 2014 until August 28, 2014. (You may submit your comments electronically via email, or by mail to:
150 Tunney's Pasture Driveway, Main Stats Building
Address Locator:  0302A
Ottawa, ON K1A 0K9

Page details

Date modified: